AIM ImmunoTech

AIMNYSE United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$7.656 M

$0.22 +2.91%

Close of 22 Sept 2026

Revenue

$88.0K

#3594 by revenue

Earnings

-$14.0M

Loss-making

Shares outstanding

30,442,139

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#149Senti BiosciencesSNTI$9.83M
#150Black TitanBTTC$7.75M
#151AIM ImmunoTechAIM$7.66M
#152Creative Medical TechnologyCELZ$6.20M
#153Liminatus PharmaLIMN$5.47M

What if AIM ImmunoTech were worth as much as…

Open the what-if tool →

Gold $30.2T

$851,469.77

Per share 3,949,303× higher

Bitcoin $1.74T

$49,049.68

Per share 227,503× higher

Nvidia $5.52T

$155,338.81

Per share 720,495× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for AIM ImmunoTech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.